President and Chief Executive Officer, Olink
Mr Björn Ekström is President and Chief Executive Officer of Olink AB, a privately held biotech supply company based in Uppsala, Sweden. Olink AB develops enabling tools and detection technologies to the life science research and diagnostics community. The technologies are available as proprietrary products and services supplied by Olink Bioscience and its licensees.
Björn Ekström has extensive experience from the biotech supply industry, including 18 years with Pharmacia Biotech (now GE Healthcare) initially as a product specialist and thereafter in leading R&D positions and last 5 years as Director of Exploratory Research. In this capacity and under his supervision several new technologies were developed that eventually were commercialized (Gyros AB, Åmic AB). In 1997, he left Pharamcia and participated in the foundation of Pyrosequencing AB (now Biotage AB), joining the company as Executive Vice President and CTO. He was deeply involved in the IPO process leading up to the listing of the Pyrosequncing AB on Stockholm Stock Exchange in 2000.
In 2003 he founded Becan, a technology and management consulting company. In 2004 he became a co-founder of Olink AB and he has since served as the President and CEO of the company.
He has served on the board of directors for several commercial companies and he is currently on the BoD of Cobolt AB, Sigolis AB and Q-Linea AB. Mr Ekström has published 6 scientific papers, contributed to 8 patents and patent applications. He has been involved in several publicly funded research projects and he has been the coordinator of an EU FP6 projects. Mr. Ekström holds an MSc in Physical Biochemistry from The Institute of Technology, Lund, Sweden.